| |
ACH-3422, A Novel HCV NS5B RNA Polymerase
Nucleotide Inhibitor, Demonstrates Improved Potency Over Sofosbuvir Against HCV Genotype-3 Replicons
In Vitro
|
| |
| |
Reported by Jules Levin
AASLD 2014
Yongsen Zhao, Steven Podos, Joanne Fabrycki, Dharaben Patel, Wengang Yang, Guangwei Yang, Jason Wiles, Avinash Phadke and Mingjun Huang
Achillion Pharmacueticals
|
|
| |
| |
|
|
|
